Effects of cannabis smoking on the respiratory system: A state-of-the-art review.

Asthma Bullous lung disease Cannabis Chronic bronchitis Lung cancer Marijuana Pulmonary aspergillosis Smoking

Journal

Respiratory medicine
ISSN: 1532-3064
Titre abrégé: Respir Med
Pays: England
ID NLM: 8908438

Informations de publication

Date de publication:
05 Dec 2023
Historique:
received: 31 08 2023
revised: 23 11 2023
accepted: 30 11 2023
pubmed: 7 12 2023
medline: 7 12 2023
entrez: 6 12 2023
Statut: aheadofprint

Résumé

The diminished perception of the health risks associated with the consumption of cannabis (marijuana) lead to a progressive increase in its inhalational use in many countries. Cannabis can be smoked through the use of joints, spliffs and blunts, and it can be vaporised with the use of hookah or e-cigarettes. Delta-9 tetrahydrocannabinol (THC) is the main psychoactive component of cannabis smoke but contains numerous other substances. While the recreational use of cannabis smoking has been legalised in several countries, its health consequences have been underestimated and undervalued. The purpose of this review is to critically review the impact of cannabis smoke on the respiratory system. Cannabis smoke irritates the bronchial tree and is strongly associated with symptoms of chronic bronchitis, with histological signs of airway inflammation and remodelling. Altered fungicidal and antibacterial activity of alveolar macrophages, with greater susceptibility to respiratory infections, is also reported. The association with invasive pulmonary aspergillosis in immunocompromised subjects is particularly concerning. Although cannabis has been shown to produce a rapid bronchodilator effect, its chronic use is associated with poor control of asthma by numerous studies. Cannabis smoking also represents a risk factor for the development of bullous lung disease, spontaneous pneumothorax and hypersensitivity pneumonitis. On the other hand, no association with the development of chronic obstructive pulmonary disease was found. Finally, a growing number of studies report an independent association of cannabis smoking with the development of lung cancer. In conclusion, unequivocal evidence established that cannabis smoking is harmful to the respiratory system. Cannabis smoking has a wide range of negative effects on respiratory symptoms in both healthy subjects and patients with chronic lung disease. Given that the most common and cheapest way of assumption of cannabis is by smoking, healthcare providers should be prepared to provide counselling on cannabis smoking cessation and inform the public and decision-makers.

Identifiants

pubmed: 38056532
pii: S0954-6111(23)00382-7
doi: 10.1016/j.rmed.2023.107494
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

107494

Informations de copyright

Copyright © 2023 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest We declare that we do not have any interests, financial or otherwise, that need to be disclosed in relation to the review article that we are submitting.

Auteurs

Lugain Khoj (L)

Division of Respirology, Western University, London, ON, Canada; Department of Internal Medicine, King Abdulaziz University, Jeddah, Saudi Arabia. Electronic address: Lugain.Khoj@lhsc.on.ca.

Vincenzo Zagà (V)

Italian Society of Tobaccology, Bologna, Italy.

Daniel L Amram (DL)

Ambulatorio per la Cessazione del Fumo di Tabacco, ASL Toscana Nord Ovest, Pontedera, Italy.

Karishma Hosein (K)

Division of Respirology, Western University, London, ON, Canada.

Giovanni Pistone (G)

Centro per il Trattamento del Tabagismo, Local Health Unit, Novara, Italy.

Mario Bisconti (M)

U.O.C. Pneumologia - Ospedale "Vito Fazzi", Lecce, Italy.

Antonella Serafini (A)

Referente C.A.F., S.C. Pneumologia, Ospedale Civile, Imperia Italy.

Liborio M Cammarata (LM)

Centro per il Trattamento del Tabagismo, Local Health Unit, Novara, Italy.

Maria Sofia Cattaruzza (MS)

Italian Society of Tobaccology, Bologna, Italy; Department of Public Health and Infectious Diseases, University of Rome "La Sapienza", Rome, Italy.

Marco Mura (M)

Division of Respirology, Western University, London, ON, Canada.

Classifications MeSH